Status:
COMPLETED
Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After Discharge
Lead Sponsor:
AstraZeneca
Conditions:
ACS
Acute Coronary Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this international study is to describe the short- and long-term (i.e. up to 2 years following the index event) antithrombotic management patterns (AMPs) in patients hospitalized for acute ...
Eligibility Criteria
Inclusion
- Diagnosis of myocardial infarction or unstable angina
- Hospitalized for the first time within 24 hours of onset of symptoms
Exclusion
- Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient (e.g. tourist, non-native speaker or does not understand the local language, psychiatric disturbances)
- Current participation in a clinical trial.
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
10568 Patients enrolled
Trial Details
Trial ID
NCT01171404
Start Date
September 1 2010
End Date
March 1 2013
Last Update
April 17 2013
Active Locations (410)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Avellaneda, Argentina
2
Research Site
Bahía Blanca, Argentina
3
Research Site
Buenos Aires, Argentina
4
Research Site
Ciudadela, Argentina